Published in Proc Soc Exp Biol Med on April 01, 1993
Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol Sci (2010) 0.93
Adverse nondrug reactions. N Engl J Med (1968) 5.26
Positive direct Coombs tests due to cephalothin. N Engl J Med (1967) 2.26
Metabolic changes associated with the cessation of cigarette smoking. Arch Environ Health (1970) 1.99
DNA chips: an array of possibilities. Nat Biotechnol (1998) 1.95
Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med (1971) 1.76
Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. Ann Intern Med (1977) 1.74
Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol (1983) 1.74
Determinants of HAART discontinuation among injection drug users. AIDS Care (2005) 1.74
The biotransformation of drugs in renal failure. Am J Med (1977) 1.70
Pulsatile ocular blood flow in asymmetric exudative age related macular degeneration. Br J Ophthalmol (2001) 1.66
Preparation and analysis of isogenic mutants in the transferrin receptor protein genes, tbpA and tbpB, from Neisseria meningitidis. Mol Microbiol (1993) 1.66
Quinidine elimination in patients with congestive heart failure or poor renal function. N Engl J Med (1974) 1.63
Clinical consequences of polymorphic acetylation of basic drugs. Clin Pharmacol Ther (1977) 1.50
Inhibition of 11beta-hydroxysteroid dehydrogenase by bioflavonoids and their interaction with furosemide and gossypol. J Lab Clin Med (1998) 1.47
High-pressure liquid chromatographic determination of ranitidine, a new H2-receptor antagonist, in plasma and urine. J Pharm Sci (1980) 1.46
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. Breast Cancer Res Treat (2001) 1.46
Hypertrichosis due to minoxidil. Br J Dermatol (1979) 1.45
Transforming growth factor-beta3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11. Endocrinology (2001) 1.45
Assessment of in vitro thyroid function tests in 100 consecutive patients referred to a thyroid clinic. Clin Endocrinol (Oxf) (1973) 1.45
Isolation and characterization of mutations in the structural gene for protease III (ptr). J Bacteriol (1979) 1.44
Influence of disease on binding of drugs to plasma proteins. Ann N Y Acad Sci (1973) 1.43
Adverse drug reactions without drugs. Lancet (1967) 1.42
Transforming prenatal care: reflections on the past and present with implications for the future. J Obstet Gynecol Neonatal Nurs (1996) 1.39
Is cadmium chloride-induced inter-sertoli tight junction permeability barrier disruption a suitable in vitro model to study the events of junction disassembly during spermatogenesis in the rat testis? Endocrinology (2001) 1.39
Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther (1978) 1.38
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
Polymorphic acetylation procainamide in man. Clin Pharmacol Ther (1975) 1.32
A 22-amino acid synthetic peptide corresponding to the second extracellular loop of rat occludin perturbs the blood-testis barrier and disrupts spermatogenesis reversibly in vivo. Biol Reprod (2001) 1.31
Optimizing metoclopramide control of cisplatin-induced emesis. Ann Intern Med (1984) 1.30
Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo. Oncogene (2011) 1.29
The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. Am J Med (1977) 1.27
Nicotine chewing gum in general practice: effect of follow up appointments. Br Med J (Clin Res Ed) (1985) 1.26
Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology (1999) 1.23
Spermatogonial stem cells alone are not sufficient to re-initiate spermatogenesis in the rat testis following adjudin-induced infertility. Int J Androl (2011) 1.18
Sensory system involvement in infantile spinal muscular atrophy. J Neurol Sci (1975) 1.17
Tight junctions in the testis: new perspectives. Philos Trans R Soc Lond B Biol Sci (2010) 1.16
Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care (1995) 1.16
Brain chirps: spectrographic signatures of epileptic seizures. Clin Neurophysiol (2000) 1.14
Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography. J Lab Clin Med (1977) 1.13
Ability of trypsin in mimicking germ cell factors that affect Sertoli cell secretory function. J Cell Physiol (1996) 1.13
Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. Clin Pharmacol Ther (1978) 1.13
Reversible inhibition of spermatogenesis in rats using a new male contraceptive, 1-(2,4-dichlorobenzyl)-indazole-3-carbohydrazide. Biol Reprod (2001) 1.13
Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am J Med (1984) 1.12
The binding of drugs to plasma proteins from patients with poor renal function. Clin Pharmacokinet (1976) 1.11
Drug complience in hypertensive patients. Br Med J (1977) 1.10
A modified procedure for replica plating of mammalian cells allowing selection of clones based on gene expression. Biotechniques (1992) 1.09
Drug metabolism in uremia. Clin Nephrol (1975) 1.09
Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmol Scand (2001) 1.08
Adult polyglucosan body disease (APBD). J Neuropathol Exp Neurol (1988) 1.08
Some smokers lie. Clin Pharmacol Ther (1994) 1.07
Identification of hormonally responsive proteins in primary Sertoli cell culture medium by anion-exchange high performance liquid chromatography. Endocrinology (1986) 1.07
Hydralazine elimination in man. Clin Pharmacol Ther (1974) 1.06
Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab (1993) 1.05
The protein binding of some drugs in plasma from patients with alcoholic liver disease. Eur J Clin Pharmacol (1975) 1.05
Rat Sertoli cell clusterin, alpha 2-macroglobulin, and testins: biosynthesis and differential regulation by germ cells. Mol Cell Endocrinol (1992) 1.04
Outbreak of Salmonella eimsbuettel in newborn infants spread by rectal thermometers. Lancet (1986) 1.04
Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. Endocrinology (1991) 1.03
Gossypol treatment of recurrent adult malignant gliomas. J Neurooncol (1999) 1.03
Childhood autism spectrum disorder in the Barwon region: a community based study. J Paediatr Child Health (2004) 1.03
Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells. Br J Cancer (1997) 1.02
The DNF15S2 locus at 3p21 is transcribed in normal lung and small cell lung cancer. Genomics (1989) 1.01
Aging and renal clearance of procainamide and acetylprocainamide. Clin Pharmacol Ther (1980) 1.01
Cryogenic surgery of the prostate. Proc R Soc Med (1968) 1.00
Estimating physical activity level: the role of domestic activities. J Epidemiol Community Health (2004) 1.00
Oestradiol-17 beta and prolactin levels in rat peripheral plasma. Br J Cancer (1975) 0.99
Alteration of drug-protein binding in renal disease. Clin Pharmacokinet (1984) 0.99
Testin secreted by Sertoli cells is associated with the cell surface, and its expression correlates with the disruption of Sertoli-germ cell junctions but not the inter-Sertoli tight junction. J Biol Chem (1998) 0.99
Visual impairment in a Taiwanese population: prevalence, causes, and socioeconomic factors. Ophthalmic Epidemiol (2001) 0.98
Treatment of the femoral neck amd trochanteric benign lesions. Clin Orthop Relat Res (1996) 0.97
Pulmonary function in the obese patient. Am J Med Sci (1967) 0.97
Germ cell-conditioned medium contains multiple factors that modulate the secretion of testins, clusterin, and transferrin by Sertoli cells. J Androl (1993) 0.96
Comparison of rapid versus slow decompression of the distended urinary bladder. Invest Urol (1976) 0.96
Regulation of Sertoli cell myotubularin (rMTM) expression by germ cells in vitro. J Androl (2001) 0.96
In vitro acetylation of drugs by human blood cells. Drug Metab Dispos (1975) 0.95
Rat clusterin isolated from primary Sertoli cell-enriched culture medium is sulfated glycoprotein-2 (SGP-2). Biochem Biophys Res Commun (1988) 0.95
Interactions of proteases and protease inhibitors in Sertoli-germ cell cocultures preceding the formation of specialized Sertoli-germ cell junctions in vitro. J Androl (1998) 0.94
Unaltered metabolism of antipyrine and tolbutamide in fasting man. Clin Pharmacol Ther (1975) 0.94
Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. N Engl J Med (1979) 0.94
Stereoselective renal tubular secretion of quinidine and quinine. Clin Pharmacol Ther (1986) 0.94
Analysis of the penetrable space within the nucleus. J Cell Sci (1978) 0.94
Lipophilic beta-blockers inhibit rat skeletal muscle mitochondrial respiration. Pharmacology (1993) 0.94
Identification of two testosterone-responsive testicular proteins in Sertoli cell-enriched culture medium whose secretion is suppressed by cells of the intact seminiferous tubule. J Biol Chem (1987) 0.93
Getting the right drug into the right patient. Nat Biotechnol (1997) 0.93
Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol (1994) 0.93
Diverse secretory patterns of clusterin by epididymis and prostate/seminal vesicles undergoing cell regression after orchiectomy. Endocrinology (1990) 0.93
The acetylator phenotype of patients with systemic lupus erythematosus. Drug Metab Dispos (1974) 0.93
Breast silicone implants and risk of systemic lupus erythematosus. J Clin Epidemiol (1994) 0.92
Changes in the expression of junctional and nonjunctional complex component genes when inter-sertoli tight junctions are formed in vitro. J Androl (2000) 0.92
A buccal cell model comet assay: development and evaluation for human biomonitoring and nutritional studies. Mutat Res (2005) 0.92
Pharmacogenomics: will the regulators approve? Nat Biotechnol (1998) 0.92
Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. N Engl J Med (1983) 0.92
Rat seminiferous tubular culture medium contains a biological factor that inhibits Leydig cell steroidogenesis: its purification and mechanism of action. Mol Cell Endocrinol (1994) 0.91
Elimination of isoniazid in patients with impaired renal function. Am Rev Respir Dis (1973) 0.91
Lupus erythematosus-like disease due to hydrazine. Am J Med (1983) 0.90
N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease. Arch Intern Med (1983) 0.90
Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors. J Clin Invest (1988) 0.90
Kinetics of metoprine, a lipid-soluble antifolate. Br J Clin Pharmacol (1981) 0.90
The effect of rigid versus flexible spinal orthosis on the gait pattern of patients with adolescent idiopathic scoliosis. Gait Posture (2007) 0.90
Quantification of prostaglandin D synthetase in cerebrospinal fluid: a potential marker for brain tumor. Biochem Mol Biol Int (1998) 0.89